Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Pharmacologic treatment of spasticity in children.

Tilton A, Vargus-Adams J, Delgado MR.

Semin Pediatr Neurol. 2010 Dec;17(4):261-7. doi: 10.1016/j.spen.2010.10.009. Review.

PMID:
21183133
2.

Pharmacologic interventions for reducing spasticity in cerebral palsy.

Patel DR, Soyode O.

Indian J Pediatr. 2005 Oct;72(10):869-72. Review.

PMID:
16272661
3.

[Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].

Yelnik AP.

Ann Readapt Med Phys. 2004 Oct;47(8):575-89. Review. French.

PMID:
15465163
4.

Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Delgado MR, Hirtz D, Aisen M, Ashwal S, Fehlings DL, McLaughlin J, Morrison LA, Shrader MW, Tilton A, Vargus-Adams J.

Neurology. 2010 Jan 26;74(4):336-43. doi: 10.1212/WNL.0b013e3181cbcd2f. Review.

5.

Drugs used to treat spasticity.

Kita M, Goodkin DE.

Drugs. 2000 Mar;59(3):487-95. Review.

PMID:
10776831
6.

Managing spasticity with drugs.

Simon O, Yelnik AP.

Eur J Phys Rehabil Med. 2010 Sep;46(3):401-10. Review.

7.

[Pharmacological treatment of spasticity in multiple sclerosis].

Heinzlef O, Monteil-Roch I.

Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S62-8. doi: 10.1016/S0035-3787(12)70049-8. Review. French.

PMID:
22721367
8.

[Treatment of spasticity].

Autti-Rämö I.

Duodecim. 1999;115(8):877-85. Review. Finnish. No abstract available.

PMID:
11859520
9.

Pharmacotherapy of spasticity in children with cerebral palsy.

Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P.

Pediatr Neurol. 2006 Jan;34(1):1-6. Review.

PMID:
16376270
10.

Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.

Koman LA, Paterson Smith B, Balkrishnan R.

Paediatr Drugs. 2003;5(1):11-23. Review.

PMID:
12513103
11.

Spasticity: revisiting the role and the individual value of several pharmacological treatments.

Lapeyre E, Kuks JB, Meijler WJ.

NeuroRehabilitation. 2010;27(2):193-200. doi: 10.3233/NRE-2010-0596. Review.

PMID:
20871149
12.

[Orally administered drugs in the treatment of spasticity].

Campistol J.

Rev Neurol. 2003 Jul 1-15;37(1):70-4. Review. Spanish.

13.

Pharmacotherapy of spasticity in children with cerebral palsy.

Chung CY, Chen CL, Wong AM.

J Formos Med Assoc. 2011 Apr;110(4):215-22. doi: 10.1016/S0929-6646(11)60033-8. Review.

14.

Principles of pharmaceutical management of spastic hypertonia.

Elovic E.

Phys Med Rehabil Clin N Am. 2001 Nov;12(4):793-816, vii. Review.

PMID:
11727721
15.

Anti-spasticity medications.

Al-Shahrani AM.

Saudi Med J. 2003 Jan;24(1):19-22. Review.

PMID:
12590267
16.

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T.

Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Review. German.

PMID:
15506048
17.

[Clinical treatment (non surgical) of spasticity in cerebral palsy].

Calderón-González R, Calderón-Sepúlveda RF.

Rev Neurol. 2002 Jan 1-15;34(1):1-6. Review. Spanish.

18.

Pharmacotherapy of spasticity: some theoretical and practical considerations.

Rice GP.

Can J Neurol Sci. 1987 Aug;14(3 Suppl):510-2. Review.

PMID:
3315153
19.

Rehabilitation of spasticity and related problems in childhood cerebral palsy.

Flett PJ.

J Paediatr Child Health. 2003 Jan-Feb;39(1):6-14. Review.

PMID:
12542805
20.

Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.

Chou R, Peterson K, Helfand M.

J Pain Symptom Manage. 2004 Aug;28(2):140-75. Review.

PMID:
15276195

Supplemental Content

Support Center